# A Study of LY3437943 in Japanese Participants With Type 2 Diabetes Mellitus (T2DM)

> **NCT04823208** · PHASE1 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 64 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** LY3437943
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04823208
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-05-24
- **Primary completion:** 2022-06-23
- **Final completion:** 2022-06-23
- **Target enrollment:** 64 (ACTUAL)
- **Last updated:** 2022-08-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04823208

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04823208, "A Study of LY3437943 in Japanese Participants With Type 2 Diabetes Mellitus (T2DM)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04823208. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*